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Abstract
Background  and  objectives: anemia  is  a  common  clinical  ﬁnding  in  intensive  care  units.  The
red blood  cell  transfusion  is  the  main  form  of  treatment,  despite  the  associated  risks.  Thus,  we
proposed  to  evaluate  the  proﬁle  of  transfusional  patients  in  different  intensive  care  units.
Methods:  prospective  analysis  of  patients  admitted  in  the  intensive  care  units  of  a  tertiary
university hospital  with  an  indication  for  transfusion  of  packed  red  blood  cells.  Demographic
proﬁle  and  transfusional  proﬁle  were  collected,  a  univariate  analysis  was  done,  and  the  results
were  considered  signiﬁcant  at  p  ≤  0.05.
Results:  408  transfusions  were  analyzed  in  71  patients.  The  mean  hemoglobin  concentration
on admission  was  9.7  ±  2.3  g/dL  and  the  pre-transfusional  concentration  was  6.9  ±  1.1  g/dL.
The  main  indications  for  transfusion  were  hemoglobin  concentration  (49%)  and  active  bleeding
(32%).  The  median  number  of  units  transfused  per  episode  was  2  (1--2)  and  the  median  storage
time  was  14  (7--21)  days.  The  number  of  patients  transfused  with  hemoglobin  levels  greater
than  7  g/dL  and  the  number  of  bags  transfused  per  episode  were  signiﬁcantly  different  among
intensive  care  units.  Patients  who  received  three  or  more  transfusions  had  longer  mechanical
ventilation  time  and  intensive  care  unit  stay  and  higher  mortality  after  60  days.  There  was  an
association  of  mortality  with  disease  severity  but  not  with  transfusional  characteristics.
Conclusions: the  practice  of  blood  products  transfusion  was  partially  in  agreement  with  the
guidelines recommended,  although  there  are  differences  in  behavior  between  the  different
proﬁles  of  intensive  care  units.  Transfused  patients  evolved  with  unfavorable  outcomes.  Despite
the  scarcity  of  blood  in  blood  ba
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ntroduction
nemia  is  a  frequent  clinical  ﬁnding  in  intensive  care  units
ICU). It  has  been  shown  that  up  to  77%  of  critically  ill
atients have  anemia  during  their  hospital  stay  and  more
han a  third  of  them  receive  blood  transfusions.1,2 Fac-
ors associated  with  the  development  of  anemia  in  the  ICU
nclude blood  loss  from  obvious  bleeding,  as  the  ‘‘iatrogenic
nemia’’ caused  by  the  serial  blood  collection  for  laboratory
ests; invasive  procedures;  nutritional  deﬁciencies  (iron,
olic acid  and  vitamin  B12);  hemolysis;  occult  blood  loss;  and
ecreased erythropoiesis  by  reduced  release  of  erythropoi-
tin, mainly  by  the  action  of  inﬂammatory  cytokines.3--6
The  red  blood  cell  transfusion  is  still  the  main
orm of  treatment  for  anemia,  despite  the  risks  of
omplications associated  with  it.  Possible  complications
nclude transmission  of  infectious  agents,  febrile  reactions,
lloimmunization, acute  lung  injury,  pulmonary  edema  ﬂuid
verload, citrate  toxicity,  and  immunosuppression,  with
onsequent increase  in  nosocomial  infections.7--11 Thus,
lood transfusion  became  a  constant  topic  of  discussion  in
CUs, and  there  is  controversy  regarding  the  possible  bene-
ts and  risks  of  maintaining  lower  levels  of  hemoglobin.12,13
rom  the  late  1990s,  studies  with  restrictive  transfusional
trategies in  the  ICU  began  to  be  published.  In  this  sense,
ébert et  al.  showed  no  beneﬁt  in  maintaining  hemoglobin
Hb) >10  g/dL,  when  compared  to  a  group  with  hemoglobin
evels between  7  and  9  g/dL,  in  patients  admitted  to  inten-
ive care  units,  with  the  possible  exception  of  those  with
cute coronary  syndromes.13 Since  its  publication,  this  study
uided the  transfusional  therapy,  and  the  current  recom-
endation is  the  transfusion  of  packed  red  blood  cells
pRBC) in  critically  ill  patients  with  Hb  less  than  7 g/dL.
Therefore,  there  is  great  interest  in  the  understanding
f transfusional  therapy  in  intensive  care  and  the  impact  of
nemia on  the  progression  and  prognosis  of  these  patients.
evertheless, in  Brazilian  hospitals,  there  are  few  the  stud-
es evaluating  transfusional  practice,  clinical  characteristics
nd outcome  of  these  patients.14--16 Thus,  the  aim  of  this
tudy was  to  evaluate  the  transfusional  proﬁle  of  differ-
nt ICUs  within  a  tertiary  university  hospital  with  analysis
f indications  and  criteria  for  transfusion.  We  also  sought
o determine  the  number  of  pRBC  units  received,  its  mean
torage time  and  possible  correlations  with  morbidity  and
ortality.
ethods
n  this  study,  patients  older  than  18  years  and  with  indi-
ation for  transfusion  of  pRBC  units  by  the  attending
hysician, being  hospitalized  in  ﬁve  ICUs  (general-SUS,
eneral-supplementary  health,  internal  medicine,  cardi-
logy and  pneumology)  of  a  tertiary  university  hospital
etween October  1  and  November  30,  2005  were  included.
o exclusion  criteria  were  used.  The  study  was  approved
y the  Ethics  in  Research  Committee  under  number  1534/04
ithout the  need  to  collecting  informed  consent,  for  this
aper deals  with  data  registry  without  intervention.
The  initial  screening  was  done  by  the  request  of  transfu-
ion records  of  the  hospital  blood  bank.  All  patients  admitted
o the  ICUs  for  whom  pRBC  units  were  administered  during
w
u
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his  period  were  included.  Two  physicians  responsible  for  the
tudy recorded  the  following  demographic  data:  age,  gen-
er, diagnosis  of  ICU  stay,  and  presence  of  comorbidities.
or assessment  of  the  severity,  Physiology  and  Acute  Chronic
ealth Evaluation  II  (APACHE  II)17 index  for  ICU  admission  and
he Sequential  Organ  Failure  Assessment  (SOFA)18 were  used
n the  day  of  transfusion  and  seven  days  later.  Regarding
ata directly  related  to  transfusions,  we  registered  the  indi-
ation  for  transfusion,  ICU  admission  and  pre-transfusional
emoglobin, storage  time  of  each  bag,  presence  of  transfu-
ional reactions  and  number  of  pRBC  units  transfused  in  the
ame transfusional  episode,  as  well  as  the  total  number  of
ags received  by  the  patient.
The  group  of  transfused  patients  was  followed  prospec-
ively with  regard  to  morbidity  and  mortality  until  hospital
ischarge, or  60  days  after  the  ﬁrst  transfusion.  Occurrence
f infectious  (as  documented  or  suspected  infection,  severe
epsis, septic  shock),  respiratory  (acute  respiratory  distress
yndrome) and  renal  (acute  renal  failure)  complications
ere recorded,  as  well  as  the  duration  of  mechanical  venti-
ation and  of  vasopressor  use,  time  of  ICU  stay,  and  survival
fter 28  and  60  days  of  transfusion.  As  part  of  the  analysis  of
orbidity,   SOFA  was  calculated,  corresponding  to  SOFA  of
th day  minus  SOFA  of  day  zero.  This  ﬁnding  was  categorized
ccording to  the  variation  occurred  in  terms  of  worsening  or
o change  (  ≥  0)  and  improvement  (  <  0).
Data were  presented  descriptively.  Continuous  varia-
les were  expressed  as  mean  and  standard  deviation,  or
edian and  percentile  25--75%,  according  to  normalcy;
he categorical  variables  were  expressed  as  a  percent-
ge. The  normalcy  of  continuous  variables  was  assessed
sing the  Kolmogorov--Smirnov  test.  Demographic  ﬁnd-
ngs and  transfusional  characteristics  of  different  ICUs,  as
ell as  the  relationship  with  the  number  of  bags,  stor-
ge time  and  the  risk  factors  for  mortality  were  analyzed
sing the  chi-square  test  (for  categorical  variables),  Stu-
ent’s t  test/ANOVA  (for  parametric  continuous  variables)
r Mann--Whitney/Kruskal--Wallis  test  (for  nonparametric
ontinuous variables).  The  correlations  among  quantitative
ariables were  tested  by  Spearman  correlation.  The  variable
‘total number  of  transfused  bags’’  was  categorized  using,
s a  cutoff  point,  the  value  obtained  in  the  receiver  operator
haracteristics (ROC)  curve  for  mortality  after  60  days.  To
nalyze the  storage  time,  we  used  the  median  value  found
n the  sample.  The  analysis  was  performed  using  SPSS  (Sta-
istical Package  for  Social  Sciences)  program  and  the  results
ere considered  signiﬁcant  at  p  ≤  0.05.
esults
eventy-one  patients  were  included  in  the  ﬁve  ICUs  partici-
ating in  the  study,  totaling  241  episodes  of  transfusion  and
08 pRBC  units.  Table  1 shows  the  global  demographics  of
he patients  and  their  division  by  ICUs.  The  median  age  of
atients was  63  (43--73)  years  and  53%  were  female.  Most
atients (84%)  had  comorbidities  at  ICU  admission  and  in  14%
f these,  prior  diagnosis  of  chronic  coronary  insufﬁciency
as present.
Table 2  describes  the  general  data  and  the  data  of  each
nit relating  to  transfusional  characteristics.  The  median
emoglobin value  that  triggered  the  transfusion  was  6.8
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Table  1  Global  and  speciﬁc  demographic  data  for  each  ICU.
Variable  Global  UTI
general
UTI
supplementary
health
UTI  internal
medicine
UTI
pneumology
UTI
cardiology
p  value
Patients  (n)  71  28  12  13  12  6  --
Age  (years)  63  (43--73)  52  (36--72)  62  (47--70)  54  (38--74)  68  (42--73)  70  (63--77)  0.45
Male gender  33  (46)  15  (52)  6  (50)  5  (39)  4  (33)  3  (50)  0.76
Admission type  0.001
Clinical 35  (49)  6  (21)  4  (33)  11  (85)  9  (75)  5  (83)
Surgical, elective  21  (27)  10  (36)  5  (41)  2  (15)  3  (25)  1  (17)
Surgical, urgency 15  (21) 12  (43)  3  (25)  0  (0)  0  (0)  0  (0)
Syndromic diagnoses 0.20
Sepsis 10  (14)  5  (18)  0  (0)  4  (31)  0  (0)  1  (17)
Severe sepsis  16  (22)  7  (25)  1  (8)  4  (31)  4  (33)  0  (0)
Septic shock  15  (21)  5  (18)  2  (17)  2  (15)  3  (25)  3  (50)
ARDS 9  (12)  1  (4)  0  (0)  0  (0)  1  (8)  1  (17)
Acute COI  3  (4)  5  (18)  2  (17)  1  (8)  1  (8)  0  (0)
Other diagnoses  18  (25)  5  (18)  7  (58)  2  (15)  3  (25)  1  (17)
Chronic COI  10  (14)  5  (18)  1  (8)  1  (8)  0  (0)  3  (50)  0.05
APACHE II  17.7  ±  5.3  17.3  ±  5.1  14.5  ±  5.5  17.6  ±  3.7  20.2  ±  7.1  20.5  ±  3.2  0.10
SOFA of  day  initial
transfusion
5  (4.7)  6  (4.7)  5  (3.10)  4  (3.7)  4  (2.6)  5  (3.7)  0.66
Hb at  ICU  admission
(g/dL)
9.7  ±  2.3  9.9  ±  2.4  10.2  ±  2.6  8.8  ±  2.2  9.6  ±  2.1  9.6  ±  1.1  0.58
Vasoprssors 47  (66)  18  (64)  5  (41)  11  (85)  7  (58)  6  (100)  0.15
Inotropes 31  (43)  19  (68)  3  (25)  3  (23)  1  (8)  5  (83)  0.001
VM use  63  (89)  27  (96)  7  (58)  12  (92)  12  (100)  5  (83)  0.08
ICU hospitalization
time  (days)
23  (11--38)  27  (15--41)  12  (2--20)  16  (10--38)  34  (9--40)  28  (14--68)  0.06
Mortality at  28  days 33  (46) 10  (36)  6  (50)  7  (54)  5  (42)  5  (83)  0.26
Mortality at  60  days 38  (54) 12  (43) 7  (58)  9  (69)  7  (58)  5  (83)  0.35
ARDS, acute respiratory distress syndrome; COI, coronary insufﬁciency; APACHE, Acute Physiologic and Chronic Health Evaluation; SOFA,
Sequential Organ Failure Assessment; ICU, intensive care unit, Hb, hemoglobin.
, p75
o
c
w
v
t
n
o
l
o
v
t
e
t
m
DResults are expressed as mean ± standard deviation, median (p25
Kruskal--Wallis, ANOVA or chi-square tests.
(6.35--7.4)  g/dL,  and  hemoglobin  concentration  was  the
main indication  for  transfusion  (49.8%).  A  signiﬁcant  per-
centage of  patients  (39.8%)  received  a  blood  transfusion
with pre-transfusion  Hb  values  >7  g/dL.  The  median  number
of pRBC  units  transfused  in  each  transfusional  episode  was
2 (1--2),  with  a  median  storage  time  for  bags  of  14  (7--21)
days. In  addition,  46.3%  of  pRBC  units  had  more  than  14  days
of storage  and  at  a  certain  point  57.7%  of  patients  received
bags with  this  characteristic.  Signiﬁcant  differences  among
the units  in  relation  to  the  median  number  of  bags  in  each
transfusional episode  were  noted,  with  one  of  the  ICUs  with
a median  of  one  unit  per  transfusion  and  all  other  with  two
units. No  signiﬁcant  transfusional  reaction  was  observed.
Table  3  shows  the  relationship  between  the  presence
of respiratory,  renal  or  infectious  complications  and  evo-
lution of  SOFA  with  the  total  number  of  transfused  bags
and the  mean  storage  time  of  pRBC  units.  These  varia-
bles did  not  correlate  signiﬁcantly  with  the  occurrence  of
infectious, respiratory,  or  renal  complications.  In  categori-
cal analysis,  patients  who  received  three  or  more  pRBC  units
had longer  ICU  stay,  longer  duration  of  mechanical  ventila-
tion and  increased  mortality  at  60  days.  The  storage  time
T
t
t
d) or number (percentage).
f  pRBC  units  does  not  correlate  with  any  of  these  out-
omes (Table  4).  Even  in  the  comparison  among  patients
ho received  at  some  point  bags  with  more  than  14  days
ersus those  who  only  received  bags  with  less  storage  time,
here was  no  signiﬁcant  difference  in  any  outcome  (data
ot shown).  Signiﬁcant  correlations,  although  weak,  were
nly found  between  the  total  number  of  transfused  bags  and
ength of  stay  in  the  ICU  (r  =  0.417,  p  <  0.001)  and  duration
f mechanical  ventilation  (r  =  0.363,  p  =  0.002).
Table 5  lists  the  analysis  of  demographic  and  transfusional
ariables with  mortality  at  60  days.  There  was  an  associa-
ion between  mortality  at  60  days  and  SOFA  of  the  day  of
nrollment in  the  study  and  the  use  of  vasopressors  during
he ICU  stay.  Transfusional  variables  did  not  correlate  with
ortality, both  at  28  and  at  60  days  (Table  5).
iscussion
his  study  characterized  the  transfusional  proﬁle  of  patients
reated in  ICUs  of  a university  hospital  undergoing  pRBC
ransfusions during  hospitalization.  Our  results  identify
ifferences in  hemoglobin  concentration  that  served  as
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Table  2  Global  and  speciﬁc  transfusional  characteristics  of  each  intensive  care  unit.
Variable  Global  UTI
general
UTI
supplementary
health
UTI  internal
medicine
UTI
pneumology
UTI
cardiology
p  value
Transfusion  episodes  (n)  241  109  25  58  27  23  --
Hb at  transfusion  indication  (g/dL)  6.8  (6.35--7.4)  6.7  (6.4--7.05)  7.2  (6.25--7.85)  6.4  (5.67--6.92)  7.4  (6.85--7.8)  7.5  (7.1--8.6)  <0.001
Transfusions with  Hb  >  7g/dL  96  (39.8)  31  (28.4)  14  (56.0)  14  (24.1)  19  (73.1)  18  (78.3)  <0.001
Indication of  transfusion  <0.001
Low hemoglobin  116  (49.8)  60  (58.8)  6  (25.0)  30  (50.8)  10  (40.0)  10  (43.5)  --
Active bleeding  74  (31.8)  27  (26.5)  3  (12.5)  27  (45.8)  4  (16.0)  13  (56.5)  --
Acute COI  14  (6.0)  6  (5.9)  5  (20.8)  0  (0)  3  (12.0)  0  (0)  --
Heart failure  6  (2.6)  0  (0)  6  (25.0)  0  (0)  0  (0)  0  (0)  --
Surgical procedure  3  (1.3)  0  (0)  0  (0)  2  (3.4)  1  (4)  0  (0)  --
Other 20  (8.6)  9  (8.8)  4  (16.7)  0  (0)  7  (28.0)  0  (0)  --
Bags/transfusional  episode  (n)  2  (1.2)  1  (1.2)  2  (1.2)  2  (2.2)  2  (1.2)  2  (2.2)  <0.001
Storage time  for  bags  (days)a 14  (7--21)  15  (10--23)  11  (6--19)  11  (6--20)  11  (6--19.5)  16  (14--21)  0.002
ICU, intensive care unit; Hb, hemoglobin; COI, coronary insufﬁciency.
Data  expressed as median (p25, p75) or number (percentage).
Kruskal--Wallis, ANOVA or chi-square tests.
a n = 408.
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Table  3  Relationship  between  total  transfused  bags  and  storage  time  with  the  presence  of  complications  during  the  intensive
care  unit  stay.
Complications  Total  of  transfunded  bags  (n)  p  value  Storage  time  (days)  p  value
Respiratory
Yes  (n  =  16)  5  (2--12.2)  0.48  15.3  (8.6--19.9)  0.38
No (n  =  55)  4  (2--7)  11.6  (6.6--20.3)
Renal
Yes (n  =  28)  4  (2--6.5)  0.57  15  (10.4--20.3)  0.30
No (n  =  43)  4  (2--12)  115  (6--18.6)
Infectious
Yes (n  =  62) 4  (2--8.5) 0.15 15  (7.3--26.5)  0.41
No (n  =  9) 3  (1--4) 12.7  (7--18.6)
Progression  of  SOFA  0  −  7a
Worsening/no  change  (n  =  26)  5  (3--13.5)  0.35  15  (7.9--22.2)  0.36
Improvement (n  =  21)  5  (2--8)  11.5  (7--16.1)
SOFA, Sequential Organ Failure Assessment.
Results expressed as median (p25, p75).
Mann--Whitney test.
a Only surviving patients.
Table  4  Analysis  of  total  transfused  bags  and  of  storage  time  in  relation  to  outcomes.
Variable Total  of  transfunded  bags Mean  time  of  storage
<3  transfusions  ≥3  transfusions  p  value  <14  days  >14  days  p  value
ICU  time  (days)  12  (4.5--24.0)  28.5  (16.2--41.5)  0.002  23  (6.5--47.7)  27  (15.5--38.5)  0.38
MV time  (days)  11  (2.5--16.0)  23  (7.2--35.7)  0.008  15  (3--35)  15  (7--30)  0.93
Vasopressor time  (days)  1  (0--4.0)  3  (0.2--8.0)  0.09  3  (1--8.5)  3  (0--6)  0.30
Mortality 28  days  7  (33.3)  26  (53.1)  0.13  18  (50)  15  (44.1)  0.62
Mortality 60  days  8  (38.1)  30  (63.8)  0.05  21  (58.3)  17  (53.1)  0.66
ICU, intensive care unit, MV, mechanical ventilation.
Results expressed as median (p25, p75) or number (percentage).
Mann--Whitney or chi-square test.
Table  5  Analysis  of  risk  factors  associated  with  mortality  after  60  days.
Variable  Survivors  (n  =  30)  Not  survivors  (n  =  38)  OR  (IC  95%)  p  value
Age  (years)  62  (33.7--70)  66.5  (45.7--73.2)  1.015  (0.988--1.043)  0.27
Male  13  (43)  19  (50)  0.765  (0.292--2.002)  0.58
APACHE  II  16.9  ±  5.1  18.5  ±  5.5  1.061  (0.963--1.169)  0.23
Admission  SOFA  (points)  5  (2.5--6.5)  6  (4--8.7).  1.228  (1.022--1.477)  0.02
Admission  Hb  (g/dl)  9.7  ±  2.0  9.7  ±  2.4  0.984  (0.790--1.225)  0.88
Pre-transfusion  Hb  (g/dl)  7.1  ±  1.1  6.9  ±  1.3  0.875  (0.594--1.228)  0.49
Storage  time  for  bags  (days)  14.2  (8.3--22.3)  11.2  (6.3--16.4)  0.949  (0.887--1.014)  0.12
Total  transfused  bags  (n)  3  (2--5.2)  5  (3--9.2)  1.072  (0.964--1.193)  0.19
Presence  of  active  bleeding  10  (30)  15  (40)  1.067  (0.326--3.945)  0.91
ICU  time  (days) 26  (12.5--40.2)  22  (10.2--37)  0.990  (0.973--1.008)  0.27
MV  time  (days) 15  (1.7--31) 16 (6.7--35)  0.997  (0.975--1.019)  0.78
Use  of  MV 25  (83)  37  (97)  7.400  (0.815--7.199)  0.04
Vasopressors  13  (43)  34  (90)  11.115  (3.144--39.299)  <0.001
APACHE, Acute Physiologic and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; Hb, hemoglobin; ICU, intensive
care therapy; MV, mechanical ventilation.
Results are expressed as mean ± standard deviation, median (25.75) or number (percentage).
Mann--Whitney, Student’s t or chi-square tests.
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ndication  for  transfusion  among  different  ICUs  with  differ-
nt patient  proﬁles.  Furthermore,  it  was  shown  that  the
torage time  of  pRBC  units  is  relatively  long.  Additionally,
he transfusion  of  three  or  more  units  of  pRBC  was  associ-
ted with  worse  outcome  in  terms  of  length  of  stay  in  ICU,
uration of  mechanical  ventilation  and  mortality  at  60  days.
In  this  study,  the  mean  values  of  pre-transfusion
emoglobin  was  very  close  to  the  limits  recommended  by
he literature  and  by  current  clinical  practice,  suggesting
hat pRBC  transfusions  in  stable  patients  be  done  only  if  the
b concentration  are  <  7  g/dL.19 However,  a  high  percent-
ge (46%)  of  the  patients  were  transfused  with  Hb  values
reater than  7  g/dL,  and  in  this  aspect,  a  signiﬁcant  dif-
erence between  the  various  ICUs  was  perceived.  There  is
onsiderable controversy  in  the  literature  regarding  trans-
usion thresholds  adopted  by  ICUs  in  different  parts  of  the
orld. Studies  of  Israel  and  the  United  Kingdom  have  shown
hat the  transfusional  thresholds  were  respectively  7.9  and
.8 g/dL.20,21 The  transfusional  thresholds  obtained  in  this
tudy are  similar  to  another  Brazilian  study  in  ICU  patients,
n which  the  transfusional  threshold  was  6.6  g/dL.16 How-
ver, in  three  other  Brazilian  studies  on  transfusion  in
ritically ill  patients, 22,23 one  of  them  multicentric, 23
he  transfusional  thresholds  remained  always  greater  than
 g/dL.  In  one  of  these  studies,  the  mean  pre-transfusion  Hb
as 8.1  g/dL.24 It  is  possible  that  aspects  such  as  availabil-
ty of  blood  products  have  inﬂuenced  these  results.  Another
ossible difference  between  ours  and  previous  studies  con-
erns the  inclusion  of  patients  from  the  ICU-Cardiology.
s we  know,  one  of  the  subgroups  of  patients  in  whom
he transfusional  threshold  is  most  discussed  is  that  with
ardiovascular diseases,  especially  coronary  insufﬁciency.
n fact,  studies  on  this  subgroup  now  demonstrate  some-
imes beneﬁcial,  sometimes  harmful,  effects  of  more  liberal
ransfusional strategies.25 Thus,  eventually  higher  transfu-
ion thresholds  in  patients  with  underlying  heart  disease  are
ustiﬁed. Another  interesting  ﬁnding  is  the  highest  value
ound in  the  supplemental  health  unit.  This  ICU  exhibits
 mixed,  semi-open  support  proﬁle,  i.e.,  assistant  physi-
ians sometimes  dictate  the  procedures.  In  this  sense,  a
ossible explanation  would  be  that  the  intensivist,  more
ccustomed to  unfavorable  evidence  for  transfusion,  has  a
ore restrictive  proﬁle,  while  other  medical  specialties  are
ore liberal.
In this  study,  we  identiﬁed  that  in  each  transfu-
ional episode  most  of  the  ICUs  infused  a  median  of
wo pRBC  units.  These  data  are  consistent  with  national
nd international16,20,22,24,26 literature,  reporting  that  most
atients received  two  units  of  pRBC  per  transfusional
pisode. However,  increasingly  the  dogma  ‘‘Who  needs  a  sin-
le transfusion  needs  no  transfusion’’  is  being  challenged,
ecause studies  show  that  the  policies  restricting  transfu-
ion, with  release  of  a  pRBC  unit  at  a  time,  are  associated
ith lower  use  of  blood  products,  without  losses  in  terms
f morbidity  and  mortality.27,28 Studies  showing  beneﬁt  with
he infusion  of  two  pRBC  units,  compared  to  a  single  bag,
re older  and  were  based  on  surgical  and  obstetric  patients.
n the  light  of  our  current  knowledge,  patients  in  whom
nly one  bag  was  transfused  exhibited  transfusion  thresh-
lds that  would  not  indicate  the  administration  of  these
omponents.28 However,  none  of  these  studies  was  done  in
CU patients.
W
p
L
MI.C.  de  Paula  et  al.
Another  interesting  ﬁnding  was  the  median  storage  time
f pRBC  units,  14  (7--21)  days,  with  46.3%  of  pRBC  units
ith more  than  14  days  old.  This  result  differs  from  that
reviously reported  in  a Brazilian  study  that  included  211
ransfusions in  one  private  hospital,  where  the  mean  storage
ime was  six  days,  with  only  20%  of  the  bags  with  more  than
5 days.29 The  storage  time  found  in  our  study  is  close  to  that
eported in  the  United  States  and  Europe,  16--21  days.1,2 In
his study  we  could  not  demonstrate  a  correlation  between
ransfusion of  pRBC  units  with  more  than  14  days  and  mor-
ality, complications  or  organ  dysfunction.  It  is  possible  that
he number  of  patients  enrolled  was  insufﬁcient.  However,
t should  be  considered  that,  despite  the  pathophysiologi-
al basis  of  transfusional  harm  with  the  use  of  pRBC  units
ith a  prolonged  storage  time,  the  literature  is  controversial
n this  respect.  In  the  CRIT  study,  for  instance,  the  storage
ime of  the  bags  also  did  not  correlate  with  morbidity  or
ortality.2
Our  study  has  identiﬁed  a  signiﬁcant  association  between
reater number  of  pRBC  units  transfused  and  unfavorable
utcomes, such  as  length  of  ICU  stay,  duration  of  mechanical
entilation and  mortality  at  60  days.  This  ﬁnding  rein-
orces data  already  well  established  in  the  literature:  a
reater need  for  transfusion  is  a  marker  of  morbidity  and
ortality,19,25 even  in  national22 studies,  and  there  is  not
ecessarily a  causal  relationship  between  the  two  events,
ut only  an  association.
The  strong  points  of  our  study  are  the  analysis  of  the
ransfusional characteristics  of  various  ICUs  in  the  same
ospital and  the  prospective  data  collection  with  clear  def-
nition of  inclusion  criteria.  On  the  other  hand,  it  has  some
imitations, for  instance,  a  small  case  series  from  a  sin-
le center  and  the  short  period  for  collecting  the  sample.
ccordingly, data  were  collected  in  2005.  However,  as  the
urrent guidelines  are  older,  we  believe  that  the  transfu-
ional practices  should  not  have  changed  signiﬁcantly  since
hen. Moreover,  given  the  observational  nature  of  the  study,
t was  not  possible  to  test  causal  relationships.
Therefore,  the  blood  component  transfusion  practice  in  a
niversity hospital  partially  agreed  with  current  guidelines,
lthough there  are  some  differences  in  behavior  among  the
ifferent proﬁles  of  ICUs.  Transfused  patients  evolved  with
nfavorable outcomes.  Despite  the  shortage  in  blood  banks,
he bags  had  a  high  mean  storage  time.  We  must  empha-
ize the  need  for  further  Brazilian  studies  on  this  subject,
n order  to  determine  the  actual  role  of  blood  component
ransfusions in  critically  ill  patients  and  their  implications
n morbidity  and  mortality.
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